Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Enterogermina vs Metronidazole in SIBO
NCT00331994Phase 4Completed
- Sponsor
- Sanofi
- Start
- Apr 2006
- Primary completion
- Jul 2008
- Modality
- Microbiome Therapeutics
- Countries
- 1
01
Overview
A Phase 4 trial of bacillus clausii in small intestinal bacterial overgrowth (SIBO), sponsored by Sanofi. Started Apr 2006; status: completed.
02
Drugs
bacillus clausii
03
Conditions
small intestinal bacterial overgrowth (SIBO)
Beyond the preview
Go deeper on NCT00331994.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00331994.